| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $173.7M | $203.4M | $259.3M |
| YoY Revenue Growth % | -14.6% | -21.5% | — |
| Gross Profit | $93.3M | $109.3M | — |
| Gross Margin % | 53.7% | 53.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$11.3M | -$22.5M | -$35.3M |
| Operating Margin % | -6.5% | -11.1% | -13.6% |
| Net Income (GAAP) | -$11.7M | -$27.4M | -$43.2M |
| EBITDA (Normalized) | -$10.4M | -$21.1M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$7.0M | -$9.7M | -$8.0M |
| Capital Expenditures (CapEx) | $1.2M | $1.8M | — |
| Free Cash Flow (FCF) | -$8.1M | -$11.5M | -$8.0M |
| FCF Margin % | -4.7% | -5.7% | -3.1% |
| Return on Invested Capital (ROIC %) | -45.0% | -45.0% | — |
| Cash & Short-Term Equivalents | $8.5M | $19.6M | — |
| Total Debt (Short + Long Term) | $6.7M | $7.5M | — |
| Total Stockholders' Equity | -$17.0M | -$8.5M | — |